Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.
Publication
, Journal Article
Wen, Y-C; Tram, VTN; Chen, W-H; Li, C-H; Yeh, H-L; Thuy Dung, PV; Jiang, K-C; Li, H-R; Huang, J; Hsiao, M; Chen, W-Y; Liu, Y-N
Published in: Cell Death Dis
January 29, 2024
Duke Scholars
Published In
Cell Death Dis
DOI
EISSN
2041-4889
Publication Date
January 29, 2024
Volume
15
Issue
1
Start / End Page
92
Location
England
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 0601 Biochemistry and Cell Biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wen, Y.-C., Tram, V. T. N., Chen, W.-H., Li, C.-H., Yeh, H.-L., Thuy Dung, P. V., … Liu, Y.-N. (2024). Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis, 15(1), 92. https://doi.org/10.1038/s41419-023-06363-1
Wen, Yu-Ching, Van Thi Ngoc Tram, Wei-Hao Chen, Chien-Hsiu Li, Hsiu-Lien Yeh, Phan Vu Thuy Dung, Kuo-Ching Jiang, et al. “Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.” Cell Death Dis 15, no. 1 (January 29, 2024): 92. https://doi.org/10.1038/s41419-023-06363-1.
Wen Y-C, Tram VTN, Chen W-H, Li C-H, Yeh H-L, Thuy Dung PV, et al. Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis. 2024 Jan 29;15(1):92.
Wen, Yu-Ching, et al. “Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.” Cell Death Dis, vol. 15, no. 1, Jan. 2024, p. 92. Pubmed, doi:10.1038/s41419-023-06363-1.
Wen Y-C, Tram VTN, Chen W-H, Li C-H, Yeh H-L, Thuy Dung PV, Jiang K-C, Li H-R, Huang J, Hsiao M, Chen W-Y, Liu Y-N. Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis. 2024 Jan 29;15(1):92.
Published In
Cell Death Dis
DOI
EISSN
2041-4889
Publication Date
January 29, 2024
Volume
15
Issue
1
Start / End Page
92
Location
England
Related Subject Headings
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
- 0601 Biochemistry and Cell Biology